≡

Recombinant Cytosolic Phospholipase A2 (PLA2G4)

c-PLA2; cPLA2; PLA2G4A; Phospholipase A2, Cytosolic; Phospholipase A2,Group IV(Cytosolic,Calcium-Dependent); Phosphatidylcholine 2-acylhydrolase; Lysophospholipase

  • Product No.RPB624Hu02
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationCytoplasm, Chromosome
  • Predicted Molecular Mass21.9kDa
  • Accurate Molecular Mass26kDa(Analysis of differences refer to the manual)
  • Residues & TagsMet1~Ser178 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 90%
  • Isoelectric Point5.9
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 182  US$ 454  US$ 908  US$ 2724  US$ 6810 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
BIOMEDICINE & PHARMACOTHERAPY The synergistic mechanism of total saponins and flavonoids in Notoginseng− Safflower pair against myocardial ischemia uncovered by an integrated … Pubmed: 32739736
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB624Hu02 Recombinant Cytosolic Phospholipase A2 (PLA2G4) Positive Control; Immunogen; SDS-PAGE; WB.
RPB624Hu01 Recombinant Cytosolic Phospholipase A2 (PLA2G4) Positive Control; Immunogen; SDS-PAGE; WB.
PAB624Hu01 Polyclonal Antibody to Cytosolic Phospholipase A2 (PLA2G4) WB; IHC
PAB624Hu02 Polyclonal Antibody to Cytosolic Phospholipase A2 (PLA2G4) WB; IHC
LAB624Hu71 Biotin-Linked Polyclonal Antibody to Cytosolic Phospholipase A2 (PLA2G4) IHC
MAB624Hu21 Monoclonal Antibody to Cytosolic Phospholipase A2 (PLA2G4) WB; IHC
MAB624Hu22 Monoclonal Antibody to Cytosolic Phospholipase A2 (PLA2G4) IHC
FAB624Hu02 Anti-Cytosolic Phospholipase A2 (PLA2G4) Monoclonal Antibody FCM
FAB624Hu04 Anti-Cytosolic Phospholipase A2 (PLA2G4) Monoclonal Antibody FCM
FAB624Hu06 Anti-Cytosolic Phospholipase A2 (PLA2G4) Monoclonal Antibody FCM